{"id":"W4387492877","doi":"10.1021/acsomega.3c05377","title":"Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5- <i>a</i> ]pyrimidines toward the Development of an In Vivo Chemical Probe for CSNK2A","year":2023,"lang":"en","type":"article","venue":"ACS Omega","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Common Fund; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases; Takeda Oncology; Genentech; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Pfizer; Bristol-Myers Squibb; North Carolina Biotechnology Center; Bayer; McGill University; University of North Carolina at Chapel Hill; U.S. Department of Defense","keywords":"In vivo; Chemistry; Pharmacokinetics; Enzyme; Covalent bond; Pharmacology; Combinatorial chemistry; Biochemistry; Stereochemistry; Organic chemistry; Medicine; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003591346,0.0004051338,0.0001870256,0.0001622813,0.0001655138,0.0002542684,0.0002860454,0.0002973461,0.0016078],"category_scores_gemma":[0.0002119421,0.0002107421,0.000173893,0.0001405576,0.0002383146,0.0002149675,0.0001395271,0.0003431557,0.0004490806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003961016,"about_ca_system_score_gemma":0.0002829722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007189692,"about_ca_topic_score_gemma":0.002371609,"domain_scores_codex":[0.9997949,0.00003973822,0.00001349427,0.000059547,0.00005671993,0.00003563287],"domain_scores_gemma":[0.9998698,0.00002577547,0.00004806962,0.00001341829,0.00002206798,0.00002090309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003694542,0.000008824841,0.00002607612,0.00001442921,0.000001182466,0.00001121984,0.000005598459,0.0001061921,0.9990587,0.00004676696,0.00002014806,0.0006639578],"study_design_scores_gemma":[0.000006941001,0.0001481786,0.0002283836,9.060039e-7,0.000002214579,0.000030824,0.000003807764,0.0004277155,0.9983749,0.000007918999,0.0007658846,0.000002269452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9542404,0.001065542,0.03948419,0.0001776957,0.00003232323,0.000368045,0.0004678315,0.0002978032,0.003866116],"genre_scores_gemma":[0.9499392,0.001322229,0.042408,0.00007925586,0.00001182869,0.0003040275,0.0006105963,0.00009206211,0.005232908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0016078,"threshold_uncertainty_score":0.005378664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1161123156095529,"score_gpt":0.4087436076058137,"score_spread":0.2926312919962608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}